V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20214914 | 20081134 | 0 | 62 | null | 2018-09-25 | 2018-09-25 | LANREOTIDE | 02 | N | LANREOTIDE | 101577670 |
| 20214916 | 20081136 | 1.7 | 115 | Not known (9) | 2016-04-12 | 2016-04-17 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 101306939 |
| 20214918 | 20081137 | 1.58 | 0 | null | 2017-12-24 | 2017-12-24 | Imatinib 400mg | 02 | null | IMATINIB | 100194808 |
| 20214919 | 20081138 | 1.71 | 94 | Palliative (P) | 2018-08-11 | 2018-08-15 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101227601 |
| 20214920 | 20081139 | 1.8 | 83.35 | Curative (C) | null | 2016-05-31 | Fluorouracil+Mitomycin+RT (Bladder) | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100742472 |
| 20214921 | 20081140 | 1.83 | 64.2 | Curative (C) | 2019-01-08 | 2019-01-24 | Fluorouracil+Mitomycin+RT (Anal Ca) | null | Y | FLUOROURACIL + MITOMYCIN + RT | 101732550 |
| 20214922 | 20081141 | 1.53 | 47 | Palliative (P) | 2017-10-30 | 2017-10-30 | Trial Unspecified | Y | N | TRIAL | 100183244 |
| 20214923 | 20081142 | null | 59 | Curative (C) | 2016-11-26 | 2016-12-24 | FLUOROURACIL + MITOMYCIN + RT | N | Y | FLUOROURACIL + MITOMYCIN + RT | 100171302 |
| 20214924 | 20081143 | 1.66 | 64 | Palliative (P) | 2018-12-07 | 2018-12-19 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100649643 |
| 20214925 | 20081144 | 1.56 | 66.8 | Palliative (P) | 2020-02-01 | 2020-02-09 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | TRIAL | 101420717 |
| 20214926 | 20081145 | 1.72 | 64.7 | Palliative (P) | 2018-08-26 | 2018-09-03 | Trial Unspecified | Y | Y | TRIAL | 100900624 |
| 20214927 | 20081146 | 1.63 | 63 | Curative (C) | null | 2017-02-02 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 101454050 |
| 20214929 | 20081148 | 1.7 | 54 | Curative (C) | 2018-02-10 | 2018-03-03 | FLUOROURACIL + MITOMYCIN + RT | 02 | null | FLUOROURACIL + MITOMYCIN + RT | 100749383 |
| 20214931 | 20081150 | 1.52 | 92 | null | 2019-05-27 | 2019-06-20 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | null | FLUOROURACIL + MITOMYCIN + RT | 101796159 |
| 20214933 | 20081151 | 1.6 | 49.3 | Curative (C) | 2018-08-26 | 2018-09-02 | Cape+Cisplatin+Trastuzumab Load | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100198499 |
| 20214934 | 20081152 | 1.81 | 53.1 | Curative (C) | 2019-09-30 | 2019-10-25 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100263636 |
| 20214935 | 20081153 | 1.62 | null | Palliative (P) | 2018-06-24 | 2018-06-24 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100269498 |
| 20214937 | 20081154 | 1.61 | 82 | Palliative (P) | 2019-11-22 | 2019-12-20 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101426743 |
| 20214939 | 20081155 | 1.84 | null | Palliative (P) | 2019-04-24 | 2019-05-23 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101357472 |
| 20214940 | 20081156 | 0 | 80 | Palliative (P) | 2016-09-27 | 2016-10-13 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | LANREOTIDE | 100136660 |
| 20214941 | 20081157 | 1.5 | 95 | Palliative (P) | 2016-05-03 | 2016-05-17 | Imatinib 400mg | 02 | N | IMATINIB | 100246251 |
| 20214942 | 20081158 | 1.67 | 127 | Curative (C) | 2018-01-23 | 2018-01-27 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | FLUOROURACIL + MITOMYCIN + RT | 101583772 |
| 20214943 | 20081159 | 1.67 | 74 | Palliative (P) | 2019-07-28 | 2019-08-11 | HCX (Cape + Cisp + Tras) - Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101356563 |
| 20214944 | 20081160 | 1.86 | 68 | Curative (C) | 2019-03-23 | 2019-04-14 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101257816 |
| 20214945 | 20081161 | 0 | 82 | Palliative (P) | 2016-08-27 | 2016-09-09 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | IMATINIB | 101395902 |
| 20214947 | 20081163 | 1.67 | 65.6 | Curative (C) | 2017-12-08 | 2018-01-02 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 101136537 |
| 20214948 | 20081164 | 1.45 | 40 | Palliative (P) | 2020-09-16 | 2020-10-08 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | IMATINIB | 100230408 |
| 20214949 | 20081165 | null | 79.8 | null | 2019-08-14 | 2019-10-19 | LANREOTIDE | 02 | null | LANREOTIDE | 101645442 |
| 20214950 | 20081166 | 1.55 | null | Palliative (P) | 2019-12-24 | 2019-12-27 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100994276 |
| 20214951 | 20081167 | 1.75 | 56.65 | null | null | 2019-09-14 | IMATINIB | 02 | null | IMATINIB | 100063268 |
| 20214952 | 20081168 | 1.79 | 75.7 | Palliative (P) | 2017-02-11 | 2017-02-11 | Cape+Cisplatin+Trastuzumab Load | 02 | N | TRIAL | 100014991 |
| 20214955 | 20081169 | 0 | null | null | 2017-06-11 | 2017-07-09 | LANREOTIDE | 02 | null | LANREOTIDE | 101504337 |
| 20214956 | 20081170 | 1.56 | 45.5 | Adjuvant (A) | 2017-05-30 | 2017-06-03 | TCX | 02 | N | IMATINIB | 101417284 |
| 20214957 | 20081171 | 1.59 | 85.7 | Curative (C) | 2017-12-31 | 2017-12-31 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 100333603 |
| 20214958 | 20081172 | 1.88 | 108 | null | 2017-06-30 | 2017-07-01 | LANREOTIDE | 02 | null | LANREOTIDE | 100715873 |
| 20214959 | 20081173 | 1.78 | 60 | Curative (C) | 2018-07-10 | 2018-07-10 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 101358801 |
| 20214960 | 20081174 | null | 61 | Palliative (P) | 2018-05-20 | 2018-05-23 | LANREOTIDE | 02 | N | LANREOTIDE | 100257326 |
| 20214964 | 20081176 | null | null | Curative (C) | 2017-02-04 | 2017-02-22 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | FLUOROURACIL + MITOMYCIN + RT | 101055371 |
| 20214966 | 20081178 | 1.69 | 65.3 | Palliative (P) | 2019-09-26 | 2019-09-27 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | TRIAL | 101333253 |
| 20214967 | 20081179 | 1.7 | 83.5 | Curative (C) | 2018-08-13 | 2018-08-13 | GO2 TRIAL | Y | N | TRIAL | 100198881 |
| 20214968 | 20081180 | 1.81 | 81 | Palliative (P) | 2016-05-09 | 2016-06-09 | TCX | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101058378 |
| 20214971 | 20081181 | 1.73 | 94 | Palliative (P) | 2020-09-04 | 2020-09-18 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101187335 |
| 20214972 | 20081182 | 1.57 | 51.6 | Curative (C) | 2016-12-14 | 2017-01-04 | Fluorouracil+Mitomycin+RT (Anal Ca) | null | N | FLUOROURACIL + MITOMYCIN + RT | 101139540 |
| 20214975 | 20081184 | 1.67 | 67 | Palliative (P) | 2017-08-20 | 2017-09-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100521151 |
| 20214976 | 20081185 | 1.68 | 93 | Palliative (P) | 2017-01-10 | 2017-02-03 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100942694 |
| 20214978 | 20081186 | 1.8 | 73.2 | Palliative (P) | 2017-10-04 | 2017-10-25 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | TRIAL | 100077899 |
| 20214979 | 20081187 | 1.6 | 0 | Curative (C) | 2016-05-03 | 2016-05-24 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100523287 |
| 20214980 | 20081188 | 1.75 | 73.2 | Palliative (P) | 2018-02-17 | 2018-03-31 | HCX (Cape + Cisp + Tras) - Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100352940 |
| 20214981 | 20081189 | 0 | 88.8 | null | 2017-03-27 | 2017-03-29 | LANREOTIDE | 02 | null | LANREOTIDE | 100274102 |
| 20214982 | 20081190 | 1.7 | 69.9 | Curative (C) | 2016-03-12 | 2016-03-12 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100293986 |